Experts remain lukewarm on the new coverage.
After numerous requests to reconsider its previous non-coverage decision, the Centers for Medicare & Medicaid Services revisited the evidence -- and officially changed its tune about coverage of positron emission tomography for beneficiaries suspected to have Alzheimer's disease.
According to a CMS release, the June 15 draft decision comes after an "exhaustive review" of evidence tipped the scales in favor of coverage for PET scans used to diagnose AD in cases where diagnosis remains uncertain despite a thorough clinical evaluation.
CMS' chief medical officer Dr. Sean Tunis says CMS plans to allow...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.
Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.
Current newsletters added each month
Fully searchable archives - over 4200 articles
ALL years/issues back to 2003 organized by year and issue
Codes mentioned in articles are linked to Code Information pages
Code Information pages link back to related articles
Access to this feature is available in the following products: